tetrabenazine has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, J; Jimenez, R; Liang, GS; O'Brien, CF; Thai-Cuarto, D | 1 |
| Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML | 1 |
| Eens, A; Janssen, PA; Leysen, JE; Wynants, J | 1 |
3 other study(ies) available for tetrabenazine and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.
Topics: Aged; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Heart Rate; Humans; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tardive Dyskinesia; Tetrabenazine; Valine | 2018 |
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.
Topics: Aged; Body Mass Index; Carbon Radioisotopes; Cardiovascular Diseases; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Imaging, Three-Dimensional; Leukoaraiosis; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Radionuclide Imaging; Reference Values; Rhombencephalon; Risk Factors; Severity of Illness Index; Tetrabenazine | 2014 |
Ketanserin reduces a particular monoamine pool in peripheral tissues.
Topics: Age Factors; Animals; Brain Chemistry; Cardiovascular Diseases; Catecholamines; Humans; Ketanserin; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Serotonin; Tetrabenazine; Vas Deferens | 1989 |